In cervical cancer research, ESTIMATE has been used to analyze gene expression data from cervical cancer tissues and to investigate the association between the tumor microenvironment and patient outcomes [17], CXCR3 axis may be a new therapeutic target for cervical cancer [17]. This evidence concerns the gene CXCR3 and cervical carcinoma.